Last update 26 Dec 2024
EDP-317
Last update 26 Dec 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms MMKI, ACTB-1003, EDP-317 + [3] |
Target |
Mechanism FGFRs antagonists(Fibroblast growth factor receptors antagonists), VEGFR2 antagonists(Vascular endothelial growth factor receptor 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC27H26F5N7O3 |
InChIKeyGZPJCJKUZPUFAL-UHFFFAOYSA-N |
CAS Registry939805-30-8 |
Related
2
Clinical Trials associated with EDP-317在中国晚期实体瘤患者中开展的EOC317片口服给药的I期临床研究
[Translation] A Phase I Clinical Study of Orally Administered EOC317 Tablets in Chinese Patients with Advanced Solid Tumors
A Phase 1 Dose Escalation Study of EOC317 in Chinese Patients With Advanced Solid Tumors
100 Clinical Results associated with EDP-317
Login to view more data
100 Translational Medicine associated with EDP-317
Login to view more data
100 Patents (Medical) associated with EDP-317
Login to view more data
100 Deals associated with EDP-317
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bile Duct Neoplasms | Phase 1 | CN | 09 Jul 2018 | |
| Bladder Cancer | Phase 1 | CN | 09 Jul 2018 | |
| Breast Cancer | Phase 1 | CN | 09 Jul 2018 | |
| Stomach Cancer | Phase 1 | CN | 09 Jul 2018 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | CN | 29 May 2018 | |
| Neoplasms | IND Approval | US | 01 Jan 2010 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free